Riskpilot← Back to searchSign inGet full accessProductLife ApS
APSActiveCVR 43253174Skelbækgade 2, 6. tvActivities of holding companies · NACE 6421Est. 2022— employees
Revenue 2024
DKK -89K
EBITDA margin
100.0%
-344% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
DKK -69K
-344% vs 2023
| Revenue | DKK -89K | — |
| EBITDA | DKK -89K | -344% |
| Net profit | DKK -69K | -344% |
| Total assets | DKK 76,5M | +0% |
| Equity | DKK 76,4M | +0% |
| Employees | — | — |
Legal name
ProductLife ApS
CVR number
43253174
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
4. maj 2022
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion.
Company purpose
Selskabets formål er direkte eller indirekte at eje kapitalandele eller andre finansielle instrumenter i virksomheder.
Address
Skelbækgade 2, 6. tv
Phone
+4524342655
Email
info@pharmait.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | — | 0 | -89 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -31 | -20 | -89 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -31 | -20 | -89 |
| Net financials | 0 | -0 | -0 |
| Profit before tax | -31 | -20 | -89 |
| Tax | -7 | -4 | -20 |
| Net profit | -24 | -16 | -69 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 76.524 | 76.509 | 76.522 |
| Equity | 76.514 | 76.498 | 76.429 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 10 | 11 | 93 |
| Total debt | 10 | 11 | 93 |
EBITDA margin
-8890700.0%
This company
15.8%
Market median
-56270353% vs market
20222024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20222024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20222024
Net profit margin
-6947000.0%
This company
8.1%
Market median
-85765532% vs market
20222024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-05-04 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
XD Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
JJ Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProductLife Group ApS | Company | 100.0% | 100.0% | 2023 |
JaJR Holding ApS | Company | 15.0% | 15.0% | 2022 |
SqWi Holding ApS | Company | 15.0% | 15.0% | 2022 |
Pharma IT ManCo ApS | Company | 33.3% | 33.3% | 2022 |
PEI Holding ApS | Company | 5.0% | 5.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProductLife Group ApS
ProductLife ApS Board members of ProductLife ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Xavier Duburq | Chief Executive Officer | 0 companies |
| Jakob Juul Rasmussen | Management | 0 companies |
| Massimo Cunico | Chairman | 0 companies |
| Søren Winkel | Board of Directors | 0 companies |